PowelHKazanjianMD

Infectious Disease • Ann Arbor, MI

Associate Professor of Medicine, University Mich Medical School

Join to view full profile

Dr. Kazanjian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kazanjian's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1982 - 1984
University of ChicagoResidency, Internal Medicine, 1979 - 1982
Tufts University School of MedicineClass of 1979

Certifications & Licensure

MI State Medical License 1994 - 2025
RI State Medical License 1984 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Origin of Antimicrobial Therapy.
Powel Kazanjian
Clinical Infectious Diseases. 2024-04-26
3 citations
Efforts to regulate antibiotic misuse in hospitals: A history.
Powel Kazanjian
Infection Control and Hospital Epidemiology. 2021-07-30
1 citations
Polio, AIDS, and Ebola: A Recurrent Ethical Dilemma.
Powel Kazanjian
Clinical Infectious Diseases. 2019-07-24

Press Mentions

What Will Future Historians Say About COVID-19?March 16th, 2021
COVID-19 Is Reshaping Michigan. It’s Not the First Epidemic to Do SoMarch 7th, 2021
Why Do Contagious Diseases Evade Eradication?December 3rd, 2020
Join now to see all

Grant Support

Tolerated Dose Of CI 1012 In LATE Stage HIV+ PatientsNational Center For Research Resources1999–2000
AIDS Patients Treated W/Sargramostim (GMCSF) &Azithromycin To Inhibit M AviumNational Center For Research Resources1998–2000
AIDS Therapy With Filgrastim &Rifabutin To Inhibit Ex Vivo Growth Of M AviumNational Center For Research Resources1998–1999
Capacity Of Neutrophils From AIDS Patients Treated With Filgrastim And RifabutinNational Center For Research Resources1997
Neutrophils In AIDS To Inhibit Ex Vivo Growth Of Opportunistic PathogensNational Center For Research Resources1996